China National Pharmaceutical Group Corporation: Enalapril Maleate Tablets Pass Consistency Evaluation.

Zhixun Finance APP News, China National Pharmaceutical Group Corporation (600420.SH) announced that the company has received the approval notice of the supplementary application for drug approval issued by the National Medical Products Administration, approving the generic drug quality and efficacy consistency evaluation of Enalapril Maleate Tablets (5mg). Enalapril Maleate Tablets is an angiotensin converting enzyme inhibitor used primarily for the treatment of essential hypertension, renal vascular hypertension, and symptomatic heart failure.